ONCOSEC MED INC's ticker is ONCS and the CUSIP is 68234L306. A total of 37 filers reported holding ONCOSEC MED INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $350,000 | -35.5% | 717,486 | -1.9% | 0.00% | – |
| Q2 2022 | $543,000 | -35.5% | 731,516 | 0.0% | 0.00% | – |
| Q1 2022 | $842,000 | +19.9% | 731,516 | 0.0% | 0.00% | – |
| Q4 2021 | $702,000 | -57.0% | 731,516 | -4.6% | 0.00% | – |
| Q3 2021 | $1,633,000 | -15.6% | 766,531 | +11.4% | 0.00% | – |
| Q2 2021 | $1,935,000 | -53.4% | 688,263 | -20.9% | 0.00% | – |
| Q1 2021 | $4,148,000 | +36.7% | 869,582 | +84.8% | 0.00% | – |
| Q4 2020 | $3,035,000 | +365.5% | 470,520 | +144.0% | 0.00% | – |
| Q3 2020 | $652,000 | +162.9% | 192,824 | +58.9% | 0.00% | – |
| Q2 2020 | $248,000 | +55.0% | 121,341 | -4.0% | 0.00% | – |
| Q1 2020 | $160,000 | -32.8% | 126,461 | -4.0% | 0.00% | – |
| Q4 2019 | $238,000 | -8.1% | 131,727 | 0.0% | 0.00% | – |
| Q3 2019 | $259,000 | -41.4% | 131,727 | -24.6% | 0.00% | – |
| Q2 2019 | $442,000 | – | 174,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avidity Partners Management LP | 3,470,000 | $16,552,000 | 0.46% |
| CAXTON CORP | 115,866 | $553,000 | 0.36% |
| Stonepine Capital Management, LLC | 94,783 | $452,000 | 0.24% |
| J. Goldman & Co LP | 987,703 | $4,711,000 | 0.15% |
| SALZHAUER MICHAEL | 37,303 | $178,000 | 0.09% |
| Holocene Advisors, LP | 642,476 | $3,065,000 | 0.02% |
| D.A. DAVIDSON & CO. | 117,000 | $558,000 | 0.01% |
| Jump Financial, LLC | 10,600 | $51,000 | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 143,938 | $687,000 | 0.00% |
| Renaissance Technologies | 340,706 | $1,625,000 | 0.00% |